-
1دورية أكاديمية
المؤلفون: Olateju, Olajumoke Adenike, Zeng, Zhen, Zakeri, Marjan, Sansgiry, Sujit S.Aff1, IDs12094024034129_cor4
المصدر: Clinical and Translational Oncology. 26(8):1908-1920
-
2كتاب إلكتروني
المؤلفون: Matoori, SimonAff5, Rahmani, SaharAff6, Aff7, Mooney, David J.Aff6, Aff7
المساهمون: Veves, Aristidis, Series EditorAff1, Aff2, Giurini, John M., editorAff3, Schermerhorn, Marc L., editorAff4
المصدر: The Diabetic Foot : Medical and Surgical Management. :287-298
-
3دورية أكاديمية
المؤلفون: Norring SA, Spigarelli MG
المصدر: Drug Design, Development and Therapy, Vol Volume 18, Pp 1143-1151 (2024)
مصطلحات موضوعية: psilocin, psychedelic, fda approval, mental health, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Kushal Seni, Aniket Saini, Rabin Debnath, Arshdeep Singh, Anjali Sharma, Deepak Singh Bisht, Viney Chawla, Pooja A Chawla
المصدر: Health Sciences Review, Vol 12, Iss , Pp 100196- (2024)
مصطلحات موضوعية: Ulcerative colitis, Etrasimod, Mechanism of action, Pharmacokinetic, FDA approval, Medicine
وصف الملف: electronic resource
-
5دورية أكاديمية
المصدر: International journal of cancer. 152(2)
مصطلحات موضوعية: Humans, Antineoplastic Agents, Antibodies, Monoclonal, Pharmaceutical Preparations, Cross-Sectional Studies, Drug Approval, FDA approval, drug development, phase I, response rate, Pediatric Research Initiative, Hematology, Clinical Research, Orphan Drug, Cancer, Rare Diseases, Clinical Trials and Supportive Activities, Development of treatments and therapeutic interventions, 5.1 Pharmaceuticals, Oncology and Carcinogenesis, Oncology & Carcinogenesis
URL الوصول: https://escholarship.org/uc/item/9p83g428
-
6دورية أكاديمية
المؤلفون: Bergold, Peter J.Aff1, Aff2, IDs13311023014269_cor1, Furhang, Rachel, Lawless, Siobhán
المصدر: Neurotherapeutics: The Journal of the American Society for Experimental Neurotherapeutics. 20(6):1546-1564
-
7دورية أكاديمية
المؤلفون: Jain Nem Kumar, Tailang Mukul, Thangavel Neelaveni, Makeen Hafiz A., Albratty Mohammed, Najmi Asim, Alhazmi Hassan Ahmad, Zoghebi Khalid, Alagusundaram Muthumanickam, Jain Hemant Kumar, Chandrasekaran Balakumar
المصدر: Acta Pharmaceutica, Vol 74, Iss 1, Pp 1-36 (2024)
مصطلحات موضوعية: fgfr, tyrosine kinase inhibitors, fda approval, erdafitinib, infigratinib, pemigatinib, futibatinib, Pharmaceutical industry, HD9665-9675
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1846-9558
-
8دورية أكاديمية
المؤلفون: Zhang, JinweiAff1, Aff2, IDs0001102301788y_cor1
المصدر: Inflammation Research. 72(9):1873-1876
-
9دورية أكاديمية
المؤلفون: Olivier, Timothée, Prasad, Vinay
مصطلحات موضوعية: Biochemistry and Cell Biology, Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Biological Sciences, Hematology, Clinical Research, Clinical Trials and Supportive Activities, 5.1 Pharmaceuticals, Development of treatments and therapeutic interventions, FDA approval, health policy, multiple myeloma, trials, Clinical Sciences, Oncology & Carcinogenesis, Biochemistry and cell biology, Oncology and carcinogenesis
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/7kh612bk
-
10كتاب إلكتروني
المؤلفون: Yaksh, Tony L.Aff3, Boyd, Robert B.Aff4, Keifer, Orion Paul, Jr.Aff5
المساهمون: Yaksh, Tony, editorAff1, Hayek, Salim, editorAff2
المصدر: Neuraxial Therapeutics : A Comprehensive Guide. :315-346